Non-invasive Evaluation of Graft Condition in Adult Patients With Kidney Transplant Using Ultrasound Localization Microscopy and Multispectral Optoacoustic Tomography
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Study ID
- NCT06472947
- Status
- Recruiting
Conditions
- Kidney Biopsy
- Kidney Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ULM and MSOT — DEVICEtransplanted kidney will be examined non-invasively with ULM and MSOT
Study Details
In this study, the condition of the kidney transplant in adults is to be assessed non-invasively using Multispectral Optoacoustic Tomography and Ultrasound Localization Microscopy (ULM). ULM imaging can be performed in a 2-dimensional and a 3-dimensional way (2D and 3D ULM). Therefore, "ULM" in the following texts and measures will refer to 2D and 3D ULM. New, non-invasive markers that allow conclusions to be drawn about the condition of the transplant should reduce the need for invasive diagnostic procedures in the future.
Key Dates
- First listed
- Jun 25, 2024
- Start date
- Jun 18, 2024
- Status verified
- Mar 2026
- Primary completion
- Jan 18, 2028
- Completion
- Jan 18, 2028
Study Design
- Enrollment
- 10 participants (estimated)
Arms
- Arm: Patient with kidney transplantIncluded are adult (\> 18 years) patients with kidney transplant where the indication for a kidney biopsy has been set during clinical routine
Primary Outcome Measure
Visualization of microvascular architecture in the transplant kidney [ Time Frame: Day1 ]
Central Contacts
- Ferdinand Hannah Knieling, PD Dr. Dr.0049 9131 85 33118
- Adrian Regensburger, PD Dr. Dr.0049 9131 33118
Related Studies
- Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister DonorPHASE1/PHASE2 · Recruiting · Jeffrey Veale, MD · Los Angeles, California
- The KidneyCARE (Community Access to Research Equity) StudyRecruiting · Tufts Medical Center · Danville, Pennsylvania
- Assessment of Biomarker-Guided CNI Substitution In Kidney TransplantationPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama
- Empagliflozin Treatment in Kidney Transplant RecipientsPHASE4 · Recruiting · VA Office of Research and Development · Hines, Illinois